{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:25:35Z","timestamp":1771655135317,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Vice-Chancellor of Research, Kerman University of Medical Sciences Kerman, Iran","award":["94.161"],"award-info":[{"award-number":["94.161"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.micpath.2018.12.040","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T00:50:31Z","timestamp":1545439831000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models"],"prefix":"10.1016","volume":"128","author":[{"given":"Mehdi","family":"Bamorovat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iraj","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Fekri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Keyhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Aflatoonian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amireh","family":"Heshmatkhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razieh Tavakoli","family":"Oliaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam Hakimi","family":"Parizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Mostafavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9731-6228","authenticated-orcid":false,"given":"Rajender S.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2018.12.040_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib2","author":"WHO"},{"issue":"8","key":"10.1016\/j.micpath.2018.12.040_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005739","article-title":"A new perspective on cutaneous leishmaniasis implications for global prevalence and burden of disease estimates","volume":"11","author":"Bailey","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of Leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/archcid.28511","article-title":"Epidemiological aspects of cutaneous leishmaniasis in Iran","volume":"10","author":"Khazaei","year":"2015","journal-title":"Arch. Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2018.12.040_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1468-3083.2010.03781.x","article-title":"Efficacy of CO2 laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate","volume":"25","author":"Shamsi Meymandi","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.micpath.2018.12.040_bib8","first-page":"289","article-title":"Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994-95","volume":"76","author":"Sharifi","year":"1998","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.micpath.2018.12.040_bib9","first-page":"291","article-title":"A new focus of cutaneous leishmaniasis caused by Leishmania tropica","volume":"23","author":"Yaghoobi-Ershadi","year":"2002","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.micpath.2018.12.040_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5144\/0256-4947.2004.98","article-title":"A new epidemic focus of zoonotic cutaneous leishmaniasis in central Iran","volume":"24","author":"Yaghoobi-Ershadi","year":"2004","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.micpath.2018.12.040_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2018.01.021","article-title":"Leishmania tropica isolates from non-healed and healed patients in Iran: a molecular typing and phylogenetic analysis","author":"Bamorovat","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2018.12.040_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/tmi.13062","article-title":"Unresponsiveness to meglumine antimoniate in anthroponotic cutaneous leishmaniasis field isolates: analysis of resistance biomarkers by gene expression profiling","author":"Oliaee","year":"2018","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micpath.2018.12.040_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192236","article-title":"Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran","volume":"13","author":"Bamorovat","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.12.040_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-3156.2001.00754.x","article-title":"Monitoring drug resistance in leishmaniasis","volume":"6","author":"Croft","year":"2001","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micpath.2018.12.040_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.micpath.2018.12.040_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1468-3083.2009.03417.x","article-title":"Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study","volume":"24","author":"El\u2010Sayed","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.micpath.2018.12.040_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/tmi.12697","article-title":"Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil","volume":"21","author":"Mistro","year":"2016","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micpath.2018.12.040_bib18","series-title":"Liposomal Amphotericin B Treatment of Cutaneous Leishmaniasis Due to Leishmania Tropica","first-page":"973","author":"Solomon","year":"2011"},{"key":"10.1016\/j.micpath.2018.12.040_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1468-3083.2004.01133.x","article-title":"A randomized, double\u2010blind, placebo\u2010controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis","volume":"19","author":"Nassiri\u2010Kashani","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.micpath.2018.12.040_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/tmi.13119","article-title":"Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomized trial","author":"Machado","year":"2018","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.micpath.2018.12.040_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-4362.1978.tb06078.x","article-title":"Levamisole and skin disease","volume":"17","author":"Allen","year":"1978","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.micpath.2018.12.040_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00128071-200405020-00004","article-title":"Levamisole in dermatology","volume":"5","author":"Scheinfeld","year":"2004","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.micpath.2018.12.040_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/cbr.2010.0902","article-title":"Cancer immunotherapy","volume":"26","author":"Dillman","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"key":"10.1016\/j.micpath.2018.12.040_bib24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/infdis\/jit410","article-title":"Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia","volume":"209","author":"Maude","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00034983.1988.11812239","article-title":"Effect of levamisole on the course of experimental leishmaniasis in Guinea-pigs and mice: haematological and immunological findings","volume":"82","author":"Rezai","year":"1988","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.micpath.2018.12.040_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.micpath.2018.12.040_bib27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/clinids\/20.5.1207","article-title":"Disseminated Acanthamoeba infection in patients with AIDS: case reports and review","volume":"20","author":"Sison","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib28","series-title":"Principles and Practice of Clinical Trial Medicine","author":"Chin","year":"2008"},{"key":"10.1016\/j.micpath.2018.12.040_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.6030\/1939-067X-3.1.8","article-title":"Clinical trial structures","volume":"3","author":"Evans","year":"2010","journal-title":"J. Exp. Stroke Transl. Med."},{"key":"10.1016\/j.micpath.2018.12.040_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171205","article-title":"A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma","volume":"12","author":"Wichert","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.12.040_bib31","series-title":"Iranian National Formulary","author":"Pharmaceutical Sciences Research Center","year":"2013"},{"key":"10.1016\/j.micpath.2018.12.040_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042070","article-title":"Leishmania promastigotes lack phosphatidylserine but bind annexin V upon permeabilization or miltefosine treatment","volume":"7","author":"Weing\u00e4rtner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.12.040_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0187756","article-title":"Calcein+\/PI- as an early apoptotic feature in Leishmania","volume":"12","author":"Basmaciyan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.12.040_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/524042","article-title":"Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru","volume":"46","author":"Llanos-Cuentas","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib35","series-title":"Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases","first-page":"1","article-title":"Control of the leishmaniases: report of a meeting of the WHO expert committee on the control of leishmaniases","author":"WHO","year":"2010"},{"key":"10.1016\/j.micpath.2018.12.040_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2174\/1381612033454685","article-title":"Low-cost anti-HIV compounds: potential application for AIDS therapy in developing countries","volume":"9","author":"Bourinbaiar","year":"2003","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.micpath.2018.12.040_bib37","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis\u2013current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.micpath.2018.12.040_bib38","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2018.12.040_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exppara.2014.04.013","article-title":"Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB\/c mice","volume":"143","author":"Kalat","year":"2014","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.micpath.2018.12.040_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2018.12.040_bib41","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/AAC.01014-09","article-title":"Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions","volume":"54","author":"Griewank","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2018.12.040_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1086\/653829","article-title":"T-bet, GATA-3, and Foxp3 expression and Th1\/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species","volume":"202","author":"D\u00edaz","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.12.040_bib43","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.intimp.2011.08.002","article-title":"Immunomodulation by chemotherapeutic agents against Leishmaniasis","volume":"11","author":"Saha","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2018.12.040_bib44","series-title":"Immunology of Pregnancy","first-page":"135","article-title":"Nerve growth factor in reproductive biology: link between the immune, endocrine and nervous system?","author":"Tometten","year":"2005"},{"key":"10.1016\/j.micpath.2018.12.040_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089043","article-title":"A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran","volume":"9","author":"Aflatoonian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2018.12.040_bib46","article-title":"Role of phytochemicals as immunomodulatory agents: a review","volume":"10","author":"Brindha","year":"2016","journal-title":"Int. J. Green Pharm."},{"key":"10.1016\/j.micpath.2018.12.040_bib47","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/all.12050","article-title":"Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis","volume":"67","author":"C\u00f3rdoba","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.micpath.2018.12.040_bib48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018315493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018315493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T15:37:15Z","timestamp":1720885035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018315493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":48,"alternative-id":["S0882401018315493"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2018.12.040","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2018.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}